Smith J L, Haegert D G, Hodges E, Stacey G N, Howell W M, Wright D H, Jones D B
Regional Immunology Service, Southampton General Hospital.
Br J Cancer. 1988 Dec;58(6):723-9. doi: 10.1038/bjc.1988.297.
A series of 21 phenotypically characterised T-cell lymphomas histologically defined as lymphocytic, lymphoblastic, immunoblastic, AILD type, pleomorphic, T-zone and Lennert's T-cell lymphoma, were investigated for T-cell receptor (TcR) and immunoglobulin (Ig) gene rearrangements. Phenotypic analyses of frozen sections and cell suspensions were heterogeneous and in many cases no single T-cell marker recognised all of the malignant cells. Data derived by staining with antibodies reactive with antigens in paraffin embedded tissue were consistent with T NHL in all cases except lymphoblastic lymphoma. TcR gene rearrangements were observed in lymphocytic, lymphoblastic and immunoblastic lymphoma, however, in the remaining 14 phenotypically and histologically defined peripheral T-cell lymphomas, 2 showed rearrangement of TcR gamma and beta genes consistent with T NHL and 2 showed Ig JH rearrangements only, suggestive of either reactive T-cell populations masking cryptic disease or presence of tumour populations with aberrant gene rearrangement and expression of T lineage antigens. No Ig or TcR gene rearrangements were found in the remaining 10 cases, in which morphologically identifiable tumour cells comprised 10-90% of the cell population. In 3/6 cases tested some CD3 positive cells failed to stain with WT31 or beta F1, monoclonal antibodies that recognise determinants on combined TcR gamma beta or TcR beta chains respectively. Whether these cases represent tumours arising from an undetermined cell of origin or polyclonal expansions of T-cells remains to be determined. Our results confirm the phenotypic heterogeneity of histologically defined peripheral T-cell lymphoma and indicate that in these particular histological subtypes gene rearrangement analysis can also yield heterogeneous results which may be unhelpful in determining cell lineage and clonality.
对一系列21例组织学上定义为淋巴细胞性、淋巴母细胞性、免疫母细胞性、AILD型、多形性、T区和 Lennert's T细胞淋巴瘤的表型特征明确的T细胞淋巴瘤进行了T细胞受体(TcR)和免疫球蛋白(Ig)基因重排研究。对冰冻切片和细胞悬液的表型分析结果各异,在许多情况下,没有单一的T细胞标志物能识别所有恶性细胞。除淋巴母细胞性淋巴瘤外,用与石蜡包埋组织中的抗原反应的抗体染色得到的数据在所有病例中均与T非霍奇金淋巴瘤一致。在淋巴细胞性、淋巴母细胞性和免疫母细胞性淋巴瘤中观察到TcR基因重排,然而,在其余14例表型和组织学定义的外周T细胞淋巴瘤中,2例显示与T非霍奇金淋巴瘤一致的TcRγ和β基因重排,2例仅显示Ig JH重排,提示要么是反应性T细胞群体掩盖了隐匿性疾病,要么是存在具有异常基因重排和T谱系抗原表达的肿瘤群体。其余10例中未发现Ig或TcR基因重排,其中形态学上可识别的肿瘤细胞占细胞群体的10 - 90%。在测试的6例中的3例中,一些CD3阳性细胞不能被WT31或βF1染色,这两种单克隆抗体分别识别组合的TcRγβ或TcRβ链上的决定簇。这些病例是代表起源于未确定细胞的肿瘤还是T细胞的多克隆扩增仍有待确定。我们的结果证实了组织学定义的外周T细胞淋巴瘤的表型异质性,并表明在这些特定的组织学亚型中,基因重排分析也可能产生异质性结果,这可能无助于确定细胞谱系和克隆性。